ASSENAGON ASSET MANAGEMENT S.A. – BioCryst Pharmaceuticals, Inc. Transaction History
ASSENAGON ASSET MANAGEMENT S.A. portfolio value:
$32.96M
portfolio value
ASSENAGON ASSET MANAGEMENT S.A. quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -17.68% | -561.71K shares | -658K | $12.6 | 2.61M |
Q2 2022 | share | Increase | +4385.73% | 3.10M shares | 32.47M | $10.58 | 3.17M |
Q1 2022 | share | Increase | +435.24% | 57.60K shares | 969K | $16.26 | 70.84K |
Q4 2021 | share | Decrease | -80.28% | -53.89K shares | -782K | $13.79 | 13.23K |
Q3 2021 | share | Decrease | -91.11% | -687.90K shares | -10.97M | $14.37 | 67.12K |
Q2 2021 | share | Increase | +1597.88% | 710.56K shares | 11.48M | $15.81 | 755.03K |
Q1 2021 | share | Increase | 0.00% | 44.46K shares | 452K | $10.17 | 44.46K |
Q3 2020 | share | Decrease | -100.00% | -303.4K shares | -1.44M | $3.44 | 0 |
Q2 2020 | share | Increase | 0.00% | 303.4K shares | 1.44M | $4.76 | 303.4K |
Q1 2020 | share | Decrease | -100.00% | -74.74K shares | -258K | $2 | 0 |
Q4 2019 | share | Increase | 0.00% | 74.74K shares | 258K | $3.45 | 74.74K |